Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Ixekizumab has known and some unexpected side effects.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Polyamines help fix DNA damage accurately in cells.

No medications for alcohol dependence have been approved for marketing yet.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Eclipta alba can be used in products to treat hair loss.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Consider NF1 in newborns with rare congenital anomalies.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Melanoma characteristics vary by age, which could help doctors with diagnosis and prevention.